(Q44492164)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12827536%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Voriconazole in the treatment of invasive mold infections in transplant recipients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12827536%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12827536%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

J Fortún

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12827536%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M A Sánchez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12827536%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

V Pintado

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12827536%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M E Alvarez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12827536%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Sánchez-Sousa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12827536%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Moreno

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12827536%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

24 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12827536%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Microbiology & Infectious Diseases

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12827536%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12827536%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

408-413

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12827536%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12827536%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10096-003-0960-0

5 November 2019

exact match

0 references

cites work

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

1 reference

12 December 2020

Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus

1 reference

12 December 2020

Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards

1 reference

12 December 2020

In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi

1 reference

12 December 2020

Amphotericin B versus amphotericin B plus 5-flucytosine: Poor results in the treatment of proven systemic mycoses in neutropenic patients

1 reference

12 December 2020

Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs

1 reference

12 December 2020

Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis

1 reference

12 December 2020

Risk factors for systemic fungal infections in liver transplant recipients

1 reference

12 December 2020

Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients

1 reference

12 December 2020

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

1 reference

12 December 2020

Invasive aspergillosis in transplant recipients

1 reference

12 December 2020

In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.

1 reference

12 December 2020

Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy

1 reference

12 December 2020

Meningitis caused by Pseudallescheria boydii treated with voriconazole

1 reference

12 December 2020

Invasive aspergillosis

1 reference

12 December 2020

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

12 December 2020

Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease.

1 reference

12 December 2020

Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis

1 reference

12 December 2020

Use of voriconazole in treatment of Scedosporium apiospermum infection: case report

1 reference

12 December 2020

Therapeutic outcome in invasive aspergillosis

1 reference

12 December 2020

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

12 December 2020

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

1 reference

12 December 2020

Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis.

1 reference

12 December 2020

Amphotericin B: 30 years of clinical experience

1 reference

12 December 2020

Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis

1 reference

12 December 2020

In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B.

1 reference

12 December 2020